NxStage Medical (NXTM) Tops Q2 EPS by 1c; Issues Mixed Guidance
Tweet Send to a Friend
NxStage Medical, Inc. (Nasdaq: NXTM) reports a Q2 loss of $0.27, 1 cent better than estimates. Q2 revenues were ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
